INVIVO AND INVITRO EXPRESSION OF HAEMOPHILUS-INFLUENZAE TYPE-B LIPOOLIGOSACCHARIDE EPITOPES

被引:12
作者
MERTSOLA, J
COPE, LD
SAEZLLORENS, X
RAMILO, O
KENNEDY, W
MCCRACKEN, GH
HANSEN, EJ
机构
[1] UNIV TEXAS,SW MED CTR,DEPT MICROBIOL,5323 HARRY HINES BLVD,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT PEDIAT,DALLAS,TX 75235
关键词
D O I
10.1093/infdis/164.3.555
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An indirect immunofluorescence system involving monoclonal antibodies (MAbs) directed against surface epitopes of Haemophilus influenzae type b (Hib) lipooligosaccharide (LOS) was used to examine individual Hib cells in cerebrospinal fluid (CSF) from infants with Hib meningitis. In four of five CSF samples studied, 100% of the bacteria bound at least one LOS-directed MAb. When the bacteria from these CSF samples were grown in broth, most of these cells lost some or all of their ability to bind the MAb(s) that were bound by the same organisms present in human CSF. When in vitro-grown cells were used for intracisternal injection of rabbits, the populations of Hib cells observed in rabbit CSF after the development of meningitis generally resembled those of the respective broth-grown inocula in terms of their LOS antigenic characteristics. Hib cell populations recovered in infant rat CSF after intranasal challenge again had LOS antigenic characteristics similar to those of the in vitro-grown challenge inocula. These results indicate that a population of Hib cells growing in the infected human host may be quite different, with regard to its LOS antigenic characteristics, from the same Hib strain growing in vitro or in vivo in animal models.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 41 条
[1]   PHENOTYPIC AND GENETIC-VARIATION IN THE SUSCEPTIBILITY OF HEMOPHILUS-INFLUENZAE TYPE-B TO ANTIBODIES TO SOMATIC ANTIGENS [J].
ANDERSON, P ;
FLESHER, A ;
SHAW, S ;
HARDING, AL ;
SMITH, DH .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (04) :885-891
[2]   PHENOTYPIC VARIATION IN EPITOPE EXPRESSION OF THE NEISSERIA-GONORRHOEAE LIPOOLIGOSACCHARIDE [J].
APICELLA, MA ;
SHERO, M ;
JARVIS, GA ;
GRIFFISS, JM ;
MANDRELL, RE ;
SCHNEIDER, H .
INFECTION AND IMMUNITY, 1987, 55 (08) :1755-1761
[3]   MODIFICATION BY SIALIC-ACID OF NEISSERIA-GONORRHOEAE LIPOOLIGOSACCHARIDE EPITOPE EXPRESSION IN HUMAN URETHRAL EXUDATES - AN IMMUNOELECTRON MICROSCOPIC ANALYSIS [J].
APICELLA, MA ;
MANDRELL, RE ;
SHERO, M ;
WILSON, ME ;
GRIFFISS, JM ;
BROOKS, GF ;
LAMMEL, C ;
BREEN, JF ;
RICE, PA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (02) :506-512
[4]   VACCINE PREVENTION OF HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE - PAST, PRESENT AND FUTURE [J].
COCHI, SL ;
BROOME, CV .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1986, 5 (01) :12-19
[5]   EFFECT OF MUTATIONS IN LIPOOLIGOSACCHARIDE BIOSYNTHESIS GENES ON VIRULENCE OF HAEMOPHILUS-INFLUENZAE TYPE-B [J].
COPE, LD ;
YOGEV, R ;
MERTSOLA, J ;
ARGYLE, JC ;
MCCRACKEN, GH ;
HANSEN, EJ .
INFECTION AND IMMUNITY, 1990, 58 (07) :2343-2351
[6]   MOLECULAR-CLONING OF A GENE INVOLVED IN LIPOOLIGOSACCHARIDE BIOSYNTHESIS AND VIRULENCE EXPRESSION BY HAEMOPHILUS-INFLUENZAE TYPE-B [J].
COPE, LD ;
YOGEV, R ;
MERTSOLA, J ;
LATIMER, JL ;
HANSON, MS ;
MCCRACKEN, GH ;
HANSEN, EJ .
MOLECULAR MICROBIOLOGY, 1991, 5 (05) :1113-1124
[7]   EFFECT OF PROBENECID ON CEREBROSPINAL-FLUID CONCENTRATIONS OF PENICILLIN AND CEPHALOSPORIN DERIVATIVES [J].
DACEY, RG ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (04) :437-441
[8]   ISOLATION OF PURE IGG1, IGG2A AND IGG2B IMMUNOGLOBULINS FROM MOUSE SERUM USING PROTEIN A-SEPHAROSE [J].
EY, PL ;
PROWSE, SJ ;
JENKIN, CR .
IMMUNOCHEMISTRY, 1978, 15 (07) :429-436
[9]   SUSCEPTIBILITY OF PHENOTYPIC VARIANTS OF HAEMOPHILUS-INFLUENZAE TYPE-B TO SERUM BACTERICIDAL ACTIVITY - RELATION TO SURFACE LIPOPOLYSACCHARIDE [J].
GILSDORF, JR ;
FERRIERI, P .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (02) :223-231
[10]   CONSERVATION OF EPITOPES IN THE OLIGOSACCHARIDE PORTION OF THE LIPOOLIGOSACCHARIDE OF HAEMOPHILUS-INFLUENZAE TYPE-B [J].
GULIG, PA ;
PATRICK, CC ;
HERMANSTORFER, L ;
MCCRACKEN, GH ;
HANSEN, EJ .
INFECTION AND IMMUNITY, 1987, 55 (03) :513-520